Link Healthcare Pty Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Link Healthcare Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12353
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Link Healthcare Pty Ltd (LINK), a subsidiary of Clinigen Group Plc, is a healthcare solution provider that provides generic products. The company offers therapeutic products, prescription, OTC medicines and medical devices in various therapeutic areas. It offers products such as relistor, anapen, hygroton, akineton, pentothal, valoid, zostrix, neomercazole, and others. LINK provides services such as supply of specialist medicines, product dossier screening and submission, and logistics services. The company’s products are used in the treatment of paracetamol overdose, emergency medicine, allergic reaction and anaphylaxis; eczema and other types of dermatitis. It offers products in therapeutic areas of anti-infective, cardiology, endocrinology, gastroenterology, intensive care, orphan drugs, palliative care, psychiatry, radiography, transplantation and toxicology. LINK is headquartered in Sydney, New South Wales, Australia.

Link Healthcare Pty Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Link Healthcare Pty Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Link Healthcare Enters Co-Marketing Agreement with Sigma-Tau 11
Link Healthcare Enters Into Agreement With Sanochemia Pharmazeutika For Secrelux 12
Acquisition 13
Clinigen Group Acquires Link Healthcare for USD78.2 Million 13
Link Healthcare Acquires Equity Pharma Holdings, Pharma And Medical Technology Company 15
Link Healthcare Pty Ltd – Key Competitors 16
Link Healthcare Pty Ltd – Key Employees 17
Link Healthcare Pty Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Link Healthcare Pty Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Link Healthcare Pty Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Link Healthcare Enters Co-Marketing Agreement with Sigma-Tau 11
Link Healthcare Enters Into Agreement With Sanochemia Pharmazeutika For Secrelux 12
Clinigen Group Acquires Link Healthcare for USD78.2 Million 13
Link Healthcare Acquires Equity Pharma Holdings, Pharma And Medical Technology Company 15
Link Healthcare Pty Ltd, Key Competitors 16
Link Healthcare Pty Ltd, Key Employees 17
Link Healthcare Pty Ltd, Other Locations 18

List of Figures
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Link Healthcare Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Link Healthcare Pty Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Link Healthcare Pty Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kala Pharmaceuticals Inc (KALA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kala Pharmaceuticals Inc (Kala Pharmaceuticals) is a clinical stage pharmaceutical company that offers nanoparticle-based treatments for ocular diseases affecting both front and back of the eye. The company’s lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase III …
  • Culp Inc (CULP):企業の財務・戦略的SWOT分析
    Culp Inc (CULP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Black Hills Corp:企業の発電所・SWOT分析2018
    Black Hills Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Celator Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celator Pharmaceuticals Inc (Celator) is a clinical-stage biopharmaceutical company that develops and distributes therapies for treating cancer disease. The company’s products include cytarabine and daunorubicin liposomal formulation, irinotecan HCI and floxuridine and hydrophobic docetaxel …
  • Exact Sciences Corp (EXAS):医療機器:M&Aディール及び事業提携情報
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …
  • HealthEquity Inc (HQY):企業の財務・戦略的SWOT分析
    Summary HealthEquity Inc (HealthEquity) is a healthcare service provider that offers health savings management services. The company provides integrated health accounts such as health savings account, health reimbursement arrangements, flexible spending accounts for health plans, and health incentiv …
  • Spotlight Innovation Inc (STLT):企業の財務・戦略的SWOT分析
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • Spire, Inc.:企業の戦略・SWOT・財務情報
    Spire, Inc. - Strategy, SWOT and Corporate Finance Report Summary Spire, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CPC Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary CPC Corp (CPC) is an integrated oil and gas company. The company explores for, develops, and produces oil and natural gas from its assets in Taiwan, Ecuador, Indonesia, Niger, Chad, Australia, the US, and Congo. CPC operates refinery and petrochemical complexes in Taoyuan and Dalin. The comp …
  • StealthGas Inc (GASS):石油・ガス:M&Aディール及び事業提携情報
    Summary StealthGas Inc (StealthGas) is an oil and gas shipping company that offers seaborne and oil and gas transportation services. The company provides transportation of petroleum and petrochemical gas products in liquefied forms. It transports byproducts of crude oil and natural gas including but …
  • Viracta Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viracta Therapeutics Inc (Viracta) is a drug development company that develops medicine to address viral associated cancer. The company's kick and kill platform is designed to treat viral associated cancers and other serious diseases. Its product development pipeline includes ebv lymphoma, e …
  • Tokyo Electric Power Company Holdings Incorporated (9501):電力:M&Aディール及び事業提携情報
    Summary Tokyo Electric Power Company Holdings Incorporated (TEPCO) is an energy utility. It generates, transmits and distributes electricity; transports fuel; and retails electricity and gas. The company produces power using coal, gas, LNG, solar, wind and hydro sources. TEPCO has presence in the en …
  • Adams Resources & Energy, Inc.:企業の戦略・SWOT・財務分析
    Adams Resources & Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Adams Resources & Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Boone Electric Cooperative:企業の発電所・SWOT分析2018
    Boone Electric Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • CIMB Group Holdings Berhad:戦略・SWOT・企業財務分析
    CIMB Group Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary CIMB Group Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • E.ON SE (EOAN)-エネルギー分野:企業M&A・提携分析
    Summary E.ON SE (E.ON), formerly E.ON AG, is an energy company that generates electricity, produces, stores, transports, and supplies gas and conducts trading, carbon sourcing, and electricity and gas distribution. It generates power from diverse fuel sources including wind, hydro, nuclear, coal, na …
  • Energa SA (ENG):企業の財務・戦略的SWOT分析
    Energa SA (ENG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Murphy Oil Corp (MUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Murphy Oil Corp (Murphy) is an international independent oil and gas exploration and production company. It explores for and produces crude oil, natural gas, and natural gas liquids. The company operates oil and gas fields in the US, Canada, Malaysia, Australia, Brunei, Vietnam and Mexico. M …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆